PERPHENAZINE Side Effects

7017802-8 | Cerebral Disorder, Dark Circles Under Eyes
on Sep 27, 2010 Male patient from UNITED STATES , weighting 160.0 lb, was diagnosed with insomnia and was treated with Perphenazine (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral disorder, dark circles under eyes. Perphenazine dosage: 8 Mg Bedtime 108660053600. During the same period patient was treated with DIPHENHYDRAMINE HCL (25 Mg Bedtime 1037575r) (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ).

6731263-5 | Hepatic Enzyme Increased
Patient was taking Perphenazine (View Usage). Patient had the following side effects: hepatic enzyme increased on May 17, 2010 from UNITED STATES Additional patient health information: Female patient , 53 years of age, weighting 250.0 lb, . Perphenazine dosage: 24 Mg Daily Po.

6448529-9 | Limb Discomfort, Tremor
Adverse event was reported on Nov 19, 2009 by a Male patient taking Perphenazine (View Usage) (Dosage: ) was diagnosed with schizophrenia, paranoid type and. Location: UNITED STATES , 27 years of age, weighting 167.4 lb, After Perphenazine was administered, patient had the following side effects: limb discomfort, tremor. Patient was hospitalized.

6427909-1 | Ill-defined Disorder
on Nov 04, 2009 Male patient from UNITED STATES , 73 years of age, was diagnosed with psychotic disorder (What is psychotic disorder?), dementia (What is dementia?) and was treated with Perphenazine (View Usage). Patient experienced the following unwanted or unexpected effects: ill-defined disorder. Perphenazine dosage: 2 Mg Bid Po. During the same period patient was treated with DONEPEZIL HCL (10 Mg Every Day Po) (View Donepezil Hcl Review and Donepezil Hcl Label ). Patient was hospitalized.


6232428-1 | Anxiety, Dry Mouth, Eyelid Oedema, Fatigue, Incontinence, Lacrimation Increased, Menstruation Irregular, Mental Status Changes, Mood Altered
on Jun 15, 2009 Female patient from UNITED STATES , weighting 190.0 lb, was diagnosed with mental disorder and was treated with Perphenazine (View Usage). Patient had the following side effects: anxiety (What is anxiety?), dry mouth, eyelid oedema, fatigue, incontinence, lacrimation increased, menstruation irregular, mental status changes, mood altered. Perphenazine dosage: 16mg X 2 8 Mg X 1 Daily, Estimate 3-08-6-09.

6149579-2 | Agitation, Anxiety, Apathy, Depression, Emotional Disorder, Hypersomnia, Insomnia, Negative Thoughts
Patient was taking Perphenazine (View Usage). After Perphenazine was administered, patient had the following side effects: agitation, anxiety (What is anxiety?), apathy, depression (What is depression?), emotional disorder, hypersomnia, insomnia, negative thoughts on Apr 06, 2009 from UNITED STATES Additional patient health information: Female patient , 35 years of age, weighting 213.0 lb, was diagnosed with anxiety (What is anxiety?), bipolar disorder (What is bipolar disorder?), schizoaffective disorder and. Perphenazine dosage: 2mg Morning Po; 4 Mg Bedtime Po. Patient was hospitalized.

5834759-3 | Dystonia
Adverse event was reported on Jul 23, 2008 by a Female patient taking Perphenazine (View Usage) (Dosage: 4 Mg; Qd) was diagnosed with depression (What is depression?), orthostatic hypotension and. Location: ITALY , 53 years of age, Patient experienced the following unwanted or unexpected effects: dystonia (What is dystonia?). During the same period patient was treated with MIDODRINE HYDROCHLORIDE (2.5 Mg, Tid) (View Midodrine Hydrochloride Review and Midodrine Hydrochloride Label ).

5811158-1 | Amnesia, Anger, Asperger's Disorder, Coeliac Disease, Cognitive Disorder, Constipation, Depression, Diarrhoea, Flushing
on Jun 30, 2008 Male patient from UNITED STATES , 44 years of age, was diagnosed with anxiety (What is anxiety?), nausea (What is nausea?) and was treated with Perphenazine (View Usage). Patient had the following side effects: amnesia, anger, asperger's disorder, coeliac disease, cognitive disorder, constipation (What is constipation?), depression (What is depression?), diarrhoea, flushing. Perphenazine dosage: 4 Mg; Tab; Po; ;hs; 2mg; Tab; Po; Tid; 2 Mg; Tab; Po; 5xd. During the same period patient was treated with IMIPRAMINE HCL (150 Mg; Hs, Po) (View Imipramine Hcl Review and Imipramine Hcl Label ), OXAZEPAM (15 Mg; Tab; Po; Tid) (View Oxazepam Review and Oxazepam Label ). Patient was hospitalized.

5789315-2 | Neutropenia
on Jun 25, 2008 Male patient from UNITED STATES , 29 years of age, weighting 205.0 lb, was treated with Perphenazine (View Usage). After Perphenazine was administered, patient had the following side effects: neutropenia. Perphenazine dosage: 64 Mg Daily Po.

5731800-3 | Crying, Musculoskeletal Discomfort
Patient was taking Perphenazine (View Usage). Patient experienced the following unwanted or unexpected effects: crying, musculoskeletal discomfort on May 06, 2008 from UNITED STATES Additional patient health information: Male patient , 55 years of age, weighting 193.6 lb, was diagnosed with schizophrenia, paranoid type and. Perphenazine dosage: 4 Mg Prn Po. Patient was hospitalized.

5674542-5 | Diaphragmatic Disorder, Tardive Dyskinesia
Adverse event was reported on Mar 19, 2008 by a Male patient taking Perphenazine (View Usage) (Dosage: 16 Mg Daily Po) was diagnosed with schizoaffective disorder and. Location: UNITED STATES , weighting 262.0 lb, Patient had the following side effects: diaphragmatic disorder, tardive dyskinesia.

5573128-0 | Blood Creatine Phosphokinase Increased, Extrapyramidal Disorder, Muscle Rigidity, Pyrexia
on Dec 20, 2007 Male patient from UNITED STATES , 20 years of age, was diagnosed with schizoaffective disorder and was treated with Perphenazine (View Usage). After Perphenazine was administered, patient had the following side effects: blood creatine phosphokinase increased, extrapyramidal disorder, muscle rigidity, pyrexia. Perphenazine dosage: 12mg Every Day Po. Patient was hospitalized.

5535770-2 | Blood Pressure Increased, Intentional Overdose, Sedation
on Dec 03, 2007 Male patient from UNITED STATES , 41 years of age, was treated with Perphenazine (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, intentional overdose, sedation. Perphenazine dosage: . During the same period patient was treated with METOPROLOL (View Metoprolol Review and Metoprolol Label ). Patient was hospitalized.

5456111-5 | Back Pain, Nocturia, Pollakiuria, Urinary Incontinence
Patient was taking Perphenazine (View Usage). Patient had the following side effects: back pain (What is back pain?), nocturia, pollakiuria, urinary incontinence (What is urinary incontinence?) on Sep 17, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 175.0 lb, . Perphenazine dosage: 1x A Day 2 A Day. Patient was hospitalized and became disabled.

5441530-3 | Breast Cancer, Chest Pain
Adverse event was reported on Aug 30, 2007 by a Female patient taking Perphenazine (View Usage) (Dosage: ) . Location: UNITED STATES , 46 years of age, weighting 132.0 lb, After Perphenazine was administered, patient had the following side effects: breast cancer (What is breast cancer?), chest pain (What is chest pain?). During the same period patient was treated with LANMICTAL (View Lanmictal Review and Lanmictal Label ), CLONEZTAN (View Cloneztan Review and Cloneztan Label ).

5397651-7 | Extrapyramidal Disorder
on Jul 23, 2007 Female patient from UNITED STATES , 52 years of age, weighting 112.0 lb, was treated with Perphenazine (View Usage). Patient experienced the following unwanted or unexpected effects: extrapyramidal disorder. Perphenazine dosage: 24 Mg Daily Po.

5385435-5 | Dystonia
on Jun 28, 2007 Female patient from ITALY , 53 years of age, was diagnosed with orthostatic hypotension and was treated with Perphenazine (View Usage). Patient had the following side effects: dystonia (What is dystonia?). Perphenazine dosage: 4 Mg, Qd, Unk. During the same period patient was treated with MIDODRINE HYDROCHLORIDE (View Midodrine Hydrochloride Review and Midodrine Hydrochloride Label ).

5344149-8 | Hypovolaemia, Metabolic Acidosis, Shock, Tumour Haemorrhage
Patient was taking Perphenazine (View Usage). After Perphenazine was administered, patient had the following side effects: hypovolaemia, metabolic acidosis, shock, tumour haemorrhage on May 30, 2007 from KOREA, REPUBLIC OF Additional patient health information: Male patient , weighting 107.1 lb, was diagnosed with nausea (What is nausea?), gastric ulcer, gastric cancer and. Perphenazine dosage: . During the same period patient was treated with RANITIDINE (View Ranitidine Review and Ranitidine Label ), SEROTONE (View Serotone Review and Serotone Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (Given Over 24 Hours) (View Fluorouracil Review and Fluorouracil Label ), OMEPRAZOLE (20 Mg) (View Omeprazole Review and Omeprazole Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), ONDASETRON (16 Mg) (View Ondasetron Review and Ondasetron Label ).

5252550-6 | Lip Pain, Lip Swelling
Adverse event was reported on Feb 27, 2007 by a Male patient taking Perphenazine (View Usage) (Dosage: 12mg Hs Po) was diagnosed with schizophrenia and. Location: UNITED STATES , weighting 187.0 lb, Patient experienced the following unwanted or unexpected effects: lip pain, lip swelling. During the same period patient was treated with TRIFLUOPERAZINE 2MG (2mg Tid Po) (View Trifluoperazine 2mg Review and Trifluoperazine 2mg Label ). Patient was hospitalized.

5195931-1 | Abasia, Diarrhoea, Drooling, Dysphagia, Mastication Disorder, Movement Disorder, Muscle Rigidity, Musculoskeletal Stiffness, Urinary Incontinence
on Dec 27, 2006 Female patient from UNITED STATES , 35 years of age, was treated with Perphenazine (View Usage). Patient had the following side effects: abasia, diarrhoea, drooling, dysphagia, mastication disorder, movement disorder (What is movement disorder?), muscle rigidity, musculoskeletal stiffness, urinary incontinence (What is urinary incontinence?). Perphenazine dosage: 8 Mg Bid Po.

5129510-9 | Cachexia, Self Injurious Behaviour, Treatment Noncompliance, Weight Decreased
on Oct 02, 2006 Male patient from UNITED STATES , 46 years of age, weighting 130.0 lb, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Perphenazine (View Usage). After Perphenazine was administered, patient had the following side effects: cachexia, self injurious behaviour, treatment noncompliance, weight decreased. Perphenazine dosage: 12 Mg (4 Mg, 3 In 1 D), Orsl. During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ). Patient was hospitalized.

5087735-5 | Feeling Abnormal
Patient was taking Perphenazine (View Usage). Patient experienced the following unwanted or unexpected effects: feeling abnormal on Aug 22, 2006 from UNITED STATES Additional patient health information: Female patient , 70 years of age, weighting 190.0 lb, was diagnosed with nausea (What is nausea?) and. Perphenazine dosage: 16 Mg 1 - 3 Times/day Oral.

5062667-7 | Feeling Abnormal
Adverse event was reported on Jul 24, 2006 by a Female patient taking Perphenazine (View Usage) (Dosage: 16 Mg 1 - 3 Times/day Oral) was diagnosed with nausea (What is nausea?) and. Location: UNITED STATES , 70 years of age, weighting 190.0 lb, Patient had the following side effects: feeling abnormal.

5029035-5 | Abdominal Distension, Surgery
on Jun 16, 2006 Female patient from MALAYSIA , 41 years of age, weighting 70.55 lb, was diagnosed with schizophrenia and was treated with Perphenazine (View Usage). After Perphenazine was administered, patient had the following side effects: abdominal distension, surgery (What is surgery?). Perphenazine dosage: 8 Mg, Bid. During the same period patient was treated with LORAZEPAM (1 Mg, Bid) (View Lorazepam Review and Lorazepam Label ), CLOZAPINE (150 Mg/d) (View Clozapine Review and Clozapine Label ). Patient was hospitalized.

4819648-5 | Extrapyramidal Disorder, Tardive Dyskinesia
on Nov 02, 2005 Male patient from UNITED STATES , 76 years of age, weighting 160.9 lb, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Perphenazine (View Usage). Patient experienced the following unwanted or unexpected effects: extrapyramidal disorder, tardive dyskinesia. Perphenazine dosage: 25 Mg Q Pm. Patient was hospitalized.

4603775-1 | Tachycardia
Patient was taking Perphenazine (View Usage). Patient had the following side effects: tachycardia on Mar 08, 2005 from Additional patient health information: Male patient , 54 years of age, weighting 125.0 lb, . Perphenazine dosage: . Patient was hospitalized.